157 related articles for article (PubMed ID: 16436346)
21. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
Najim RA; Sharquie KE; Abu-Raghif AR
J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
Kato Y; Yamamoto T
Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
[TBL] [Abstract][Full Text] [Related]
23. Von Willebrand factor antigen levels in Behçet disease.
Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
[TBL] [Abstract][Full Text] [Related]
24. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
[TBL] [Abstract][Full Text] [Related]
25. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
26. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
28. Peripheral insulin resistance in patients with Behçet's disease.
Erdem H; Dinc A; Pay S; Simsek I; Turan M
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):391-5. PubMed ID: 16643134
[TBL] [Abstract][Full Text] [Related]
29. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
[TBL] [Abstract][Full Text] [Related]
31. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
32. Study of the correlation of serum selenium level with Behcet's disease.
Esalatmanesh K; Jamshidi A; Shahram F; Davatchi F; Masoud SA; Soleimani Z; Salesi M; Ghaffarpasand I
Int J Rheum Dis; 2011 Oct; 14(4):375-8. PubMed ID: 22004235
[TBL] [Abstract][Full Text] [Related]
33. Classifying patients with Behçet's disease for disease severity, using a discriminating analysis method.
Polat M; Vahaboglu G; Onde U; Eksioglu M
Clin Exp Dermatol; 2009 Mar; 34(2):151-5. PubMed ID: 19187295
[TBL] [Abstract][Full Text] [Related]
34. Activated protein C resistance and its correlation with thrombophlebitis in Behçet's disease.
Kavala M; Namdar ND; Kocatürk E; Türkoğlu Z; Zindanci I
Acta Dermatovenerol Croat; 2011; 19(2):87-90. PubMed ID: 21703154
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.
Zorio E; Falco C; Arnau MA; España F; Osa A; Ramon LA; Castello R; Almenar L; Palencia MA; Estelles A
Haematologica; 2006 Apr; 91(4):562-5. PubMed ID: 16585023
[TBL] [Abstract][Full Text] [Related]
36. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
37. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
38. Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Kacaroglu H; Tosun O; Yavuzer U; Alpsoy E; Yegin O
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):950-7. PubMed ID: 18355201
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
40. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]